Form 4: Blend Labs Director Sells Shares Under 10b5-1 Plan

Blend Labs Director Eric H. Woersching sold 20,000 shares of Class A Common Stock for $4.005 per share under a pre-arranged trading plan.

Summary

• Director Eric H. Woersching of Blend Labs, Inc. disposed of 20,000 shares of Class A Common Stock.
• The transaction occurred on September 5, 2025, at a price of $4.005 per share.
• Following the sale, Mr. Woersching beneficially owns 30,000 shares directly.
• The sale was executed under a Rule 10b5-1 trading plan established on March 4, 2025.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even under a 10b5-1 plan, generally carries a slightly negative sentiment as it reduces insider ownership. However, the pre-planned nature mitigates some of the immediate negative implications, suggesting it's not based on new, adverse information.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction rather than an immediate reaction to new, non-public information.

Negatives

• A director selling shares reduces insider ownership, which can be perceived negatively by the market.
• The sale of 20,000 shares represents a reduction in the director's direct holdings.

Risks

• Potential negative market perception due to insider selling, which could put downward pressure on the stock price.
• Reduced alignment of interests between the director and common shareholders due to decreased equity stake.

Future Outlook

No specific forward-looking statements or guidance are provided in this transactional filing.

Management Comments

• The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The reported transaction is an insider sale of 20,000 shares of Class A Common Stock by Director Eric H. Woersching.

Stakeholder Impact

• Shareholders may interpret the insider sale as a negative signal, potentially leading to downward pressure on the stock price due to concerns about future performance or valuation.

Key Dates

Recommendation

The sale of 20,000 shares by Director Eric H. Woersching, while a reduction in insider ownership, was executed under a pre-arranged Rule 10b5-1 trading plan. This suggests the transaction was scheduled and not necessarily indicative of new, adverse company-specific information. While insider selling can create negative sentiment, the planned nature mitigates the immediate concern. Investors should monitor future insider activity and company fundamentals rather than reacting solely to this single planned transaction.

Keywords

Blend Labs, BLND, Insider Sale, Form 4, Director Transaction, Equity Disposal, 10b5-1 Plan